Liposomes as vehicles for the presentation of a synthetic peptide containing an epitope of hepatitis A virus
- 30 September 1999
- Vol. 18 (3-4) , 276-283
- https://doi.org/10.1016/s0264-410x(99)00198-x
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Enhancement of the immunogenicity of a synthetic peptide bearing a VP3 epitope of hepatitis A virusFEBS Letters, 1998
- Analysis of the Interaction with Biomembrane Models of the HAV-VP3(101−121) Sequence Conjugated to Synthetic Branched Chain Polypeptide Carriers with a Poly[l-Lysine] BackboneLangmuir, 1998
- Liposomes as Drug Delivery System: A Strategic Approach for the Treatment of HIV InfectionJournal of Drug Targeting, 1998
- Uses of Biosensors in the Study of Viral AntigensImmunological Investigations, 1997
- LiposomenDrugs, 1997
- Synthesis, lipophilic derivatization and interaction with liposomes of HAV–VP3 (102–121) sequence by using spectroscopic techniquesThe Analyst, 1996
- Liposomes as delivery systems in the prevention and treatment of infectious diseasesPharmacy World & Science, 1995
- Immunogenicity of new virosome influenza vaccine in elderly peopleThe Lancet, 1994
- Liposomal amphotericin B in drug-resistant visceral leishmaniasisThe Lancet, 1991
- Adjuvant-free IgG responses induced with antigen coupled to antibodies against class II MHCNature, 1987